- Subject must be either (1) at high risk for candidiasis (1 month -
(2) have a definitive diagnosis of invasive candidiasis/candidemia (ICC) (All age
- Male and female participants from 1 month to less than 18 years of age.
- Any patients with allergy to the drug; and any pregnant female or lactating.
- Failed previous antifungal therapy or expected to live
- Patients with documented or suspected Candida meningitis.